LPL Financial LLC Acquires 158,405 Shares of LifeVantage Co. (NASDAQ:LFVN)

LPL Financial LLC increased its holdings in shares of LifeVantage Co. (NASDAQ:LFVN) by 301.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 211,039 shares of the company’s stock after purchasing an additional 158,405 shares during the period. LPL Financial LLC’s holdings in LifeVantage were worth $3,700,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Barclays PLC grew its position in shares of LifeVantage by 38.2% during the 3rd quarter. Barclays PLC now owns 41,966 shares of the company’s stock worth $507,000 after buying an additional 11,608 shares during the period. HighTower Advisors LLC bought a new position in LifeVantage during the third quarter worth $638,000. Ritholtz Wealth Management grew its holdings in LifeVantage by 65.2% in the fourth quarter. Ritholtz Wealth Management now owns 47,348 shares of the company’s stock worth $830,000 after purchasing an additional 18,682 shares during the period. Bank of New York Mellon Corp increased its stake in LifeVantage by 43.9% in the fourth quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company’s stock valued at $1,300,000 after purchasing an additional 22,620 shares in the last quarter. Finally, Hillsdale Investment Management Inc. raised its holdings in shares of LifeVantage by 7.3% during the fourth quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company’s stock valued at $258,000 after purchasing an additional 1,000 shares during the period. 35.32% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently commented on LFVN. Lake Street Capital started coverage on LifeVantage in a research note on Thursday, December 19th. They issued a “buy” rating and a $26.00 target price for the company. Craig Hallum assumed coverage on LifeVantage in a research note on Tuesday, January 14th. They issued a “buy” rating and a $35.00 price objective for the company.

LifeVantage Trading Down 9.7 %

Shares of LFVN stock opened at $13.82 on Friday. The firm has a fifty day simple moving average of $16.70 and a two-hundred day simple moving average of $16.25. LifeVantage Co. has a 12 month low of $5.22 and a 12 month high of $27.38. The firm has a market capitalization of $173.45 million, a PE ratio of 24.68 and a beta of 0.75.

LifeVantage (NASDAQ:LFVN) last posted its earnings results on Wednesday, February 5th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.14 by $0.08. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%.

LifeVantage Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 1.16%. The ex-dividend date was Monday, March 3rd. LifeVantage’s dividend payout ratio (DPR) is presently 28.57%.

Insider Activity

In related news, Director Raymond B. Greer sold 8,000 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $20.15, for a total value of $161,200.00. Following the completion of the sale, the director now directly owns 99,288 shares of the company’s stock, valued at approximately $2,000,653.20. This represents a 7.46 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 20.65% of the company’s stock.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.